Quick Answer
ANI PHARMACEUTICALS INC reported Operating Income of $111.09 million for fiscal year 2025.
ANI PHARMACEUTICALS INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $111.09M | +18922.8% |
| 2024 | $584.0K | -98.8% |
| 2023 | $46.97M | +233.1% |
| 2022 | -$35.28M | +11.3% |
| 2021 | -$39.79M | -148.5% |
| 2020 | -$16.02M | -198.0% |
| 2019 | $16.35M | -53.8% |
| 2018 | $35.36M | +24.8% |
| 2017 | $28.33M | +41.1% |
| 2016 | $20.08M | -38.6% |
| 2015 | $32.70M | +63.5% |
| 2014 | $20.01M | +2127.8% |
| 2013 | $898.0K | +2238.1% |
| 2012 | -$42.0K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $36.24M | +276.6% | +160.9% |
| June 30, 2025 | $13.89M | +168.8% | -47.0% |
| March 31, 2025 | $26.19M | +29.0% | +227.7% |
| September 30, 2024 | -$20.52M | -214.3% | -497.0% |
| June 30, 2024 | $5.17M | -58.3% | -74.6% |
| March 31, 2024 | $20.31M | +105.3% | +13.2% |
| September 30, 2023 | $17.95M | +459.3% | +44.7% |
| June 30, 2023 | $12.40M | +196.0% | +25.3% |
- ANI PHARMACEUTICALS INC showed an increase of +18922.8% in Operating Income compared to the prior fiscal year.
- Over the 2012–2025 period, ANI PHARMACEUTICALS INC’s operating income has grown by 264607.1% (from -$42.0 thousand to $111.09 million).
- The most recent figure is from ANI PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: